Harmony Biosciences Holdings, Inc. (HRMY)
39.65
+0.38
(+0.97%)
USD |
NASDAQ |
Dec 11, 11:50
Harmony Biosciences Holdings Market Cap: 2.284B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 9.145B |
| Halozyme Therapeutics, Inc. | 7.331B |
| Capricor Therapeutics, Inc. | 1.256B |
| Nurix Therapeutics, Inc. | 1.512B |
| Moderna, Inc. | 11.50B |
Market Cap Related Metrics
| PE Ratio | 12.49 |
| PS Ratio | 2.807 |
| PEG Ratio | 0.2482 |
| Price to Book Value | 2.735 |
| Price to Free Cash Flow | 7.809 |
| Price | 39.65 |
| Earnings Yield | 8.01% |
| PEGY Ratio | 0.2482 |
| Operating PE Ratio | 10.27 |
| Normalized PE Ratio | 12.49 |